JCR Pharmaceuticals Co., Ltd. Financial Overview
JCR Pharmaceuticals Co., Ltd.'s market cap is currently ¥87.37B. The company's EPS TTM is ¥18.51; its P/E ratio is -36.46; and it has a dividend yield of 2.73%. JCR Pharmaceuticals Co., Ltd. is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥-1.07. See an overview of income statement, balance sheet, and cash flow financials.
